{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T09:26:35Z","timestamp":1794216395266,"version":"4.8.0"},"reference-count":60,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","license":[{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by persistent synovial inflammation, bone erosion, cartilage destruction, and debilitating pain. Current therapies often fall short in preventing structural damage and restoring immune balance. To address these limitations, we evaluated MRG-001 \u2013 a fixed-dose combination of plerixafor (AMD3100) and low-dose tacrolimus (FK506) with reported immunoregulatory and regenerative potential \u2013 in preclinical models of RA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>The therapeutic efficacy of MRG-001 was assessed in collagen-induced arthritis and collagen antibody-induced arthritis mouse models. Mice received subcutaneous MRG-001, and clinical, histological, molecular, and behavioral endpoints were evaluated to examine inflammation, immune modulation, bone integrity, angiogenesis, and pain.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      MRG-001 treatment significantly reduced joint swelling, arthritis scores, and pro-inflammatory cytokine expression (TNF-\u03b1, IL-6, IL-17a) in both models. It was associated with mobilization of CD45\n                      <jats:sup>\u2212<\/jats:sup>\n                      Sca1\u207aCD29\u207a mesenchymal stem cells, increased CD4\u207aCD25\u207aFoxp3\u207a regulatory T cells, and reduced CD4\u207aROR\u03b3t\u207a Th17 cells in peripheral blood. MRG-001 preserved cartilage integrity was associated with reduced osteoclast-mediated bone erosion, and improved trabecular bone structure. It was associated with reduced fibroblast-like synoviocyte activation, lower TGF-\u03b2 signaling activity, and decreased RANKL expression in joint tissues. Additionally, MRG-001 was associated with reduced pathological angiogenesis (CD31\u207aEMCN\u207a vessels) and sensory nerve innervation (PGP9.5\u207a, CGRP\u207a fibers), corresponding with improved pain-like behaviors and physical function.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>MRG-001 exerts broad therapeutic effects in RA by modulating immune responses, preserving joint architecture, and alleviating pain. These findings support its potential as a novel, multi-modal disease-modifying therapy for RA and warrant further clinical investigation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/js9.0000000000005353","type":"journal-article","created":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T18:01:49Z","timestamp":1778090509000},"page":"13753-13769","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Mobilizing stem cells and inhibition of autoimmunity synergistically modify autoimmune disease to relieve pain: a potential MRG-001 therapy for rheumatoid arthritis"],"prefix":"10.1097","volume":"112","author":[{"given":"Weixin","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Orthopedic Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Lopez","sequence":"additional","affiliation":[{"name":"Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Wan","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junying","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell","family":"Wesson","sequence":"additional","affiliation":[{"name":"Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoli","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Cao","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,4,30]]},"reference":[{"key":"R1-20261109","doi-asserted-by":"crossref","first-page":"2019\u201333","DOI":"10.1016\/S0140-6736(23)01525-8","article-title":"Rheumatoid arthritis","volume":"402","author":"Di Matteo","year":"2023","journal-title":"Lancet"},{"key":"R2-20261109","doi-asserted-by":"crossref","DOI":"10.3390\/cells10112857","article-title":"Management of rheumatoid arthritis: an overview","author":"Radu","year":"2021","journal-title":"Cells"},{"key":"R3-20261109","doi-asserted-by":"crossref","first-page":"533\u201342","DOI":"10.1016\/j.medcli.2023.07.014","article-title":"Rheumatoid arthritis","volume":"161","author":"D\u00edaz-Gonz\u00e1lez","year":"2023","journal-title":"Med Clin (Barc)"},{"key":"R4-20261109","first-page":"e32","article-title":"What is rheumatoid arthritis","author":"Gravallese","year":"2024","journal-title":"N Engl J Med"},{"key":"R5-20261109","doi-asserted-by":"crossref","first-page":"404\u201313","DOI":"10.31138\/mjr.301223.eaf","article-title":"Epidemiology and risk factors for rheumatoid arthritis development","volume":"34","author":"Venetsanopoulou","year":"2023","journal-title":"Mediterr J Rheumatol"},{"key":"R6-20261109","doi-asserted-by":"crossref","first-page":"e070856","DOI":"10.1136\/bmj-2022-070856","article-title":"Therapeutic advances in rheumatoid arthritis","volume":"384","author":"Brown","year":"2024","journal-title":"Bmj"},{"key":"R7-20261109","doi-asserted-by":"crossref","first-page":"686155","DOI":"10.3389\/fimmu.2021.686155","article-title":"Promising therapeutic targets for treatment of rheumatoid arthritis","volume":"12","author":"Huang","year":"2021","journal-title":"Front Immunol"},{"key":"R8-20261109","doi-asserted-by":"crossref","first-page":"529\u201342","DOI":"10.1056\/NEJMra2103726","article-title":"Rheumatoid arthritis - Common origins, divergent mechanisms","volume":"388","author":"Gravallese","year":"2023","journal-title":"N Engl J Med"},{"key":"R9-20261109","doi-asserted-by":"crossref","first-page":"107392","DOI":"10.1016\/j.intimp.2021.107392","article-title":"Fibroblast-like synoviocytes in rheumatoid arthritis: surface markers and phenotypes","volume":"93","author":"Wu","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"R10-20261109","doi-asserted-by":"crossref","first-page":"316\u201333","DOI":"10.1038\/s41584-020-0413-5","article-title":"Restoring synovial homeostasis in rheumatoid arthritis by targeting fibroblast-like synoviocytes","volume":"16","author":"Nygaard","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"R11-20261109","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s13075-024-03343-4","article-title":"Targeting pathogenic fibroblast-like synoviocyte subsets in rheumatoid arthritis","volume":"26","author":"Qian","year":"2024","journal-title":"Arthritis Res Ther"},{"key":"R12-20261109","doi-asserted-by":"crossref","first-page":"1200\u201310","DOI":"10.1038\/s41590-023-01527-9","article-title":"Drivers of heterogeneity in synovial fibroblasts in rheumatoid arthritis","volume":"24","author":"Smith","year":"2023","journal-title":"Nat Immunol"},{"key":"R13-20261109","doi-asserted-by":"crossref","first-page":"6221","DOI":"10.1038\/s41467-022-33785-w","article-title":"Systems-biology analysis of rheumatoid arthritis fibroblast-like synoviocytes implicates cell line-specific transcription factor function","volume":"13","author":"Ainsworth","year":"2022","journal-title":"Nat Commun"},{"key":"R14-20261109","doi-asserted-by":"crossref","first-page":"2033\u201343","DOI":"10.1002\/jbmr.2550","article-title":"Aberrant activation of TGF-\u03b2 in subchondral bone at the onset of rheumatoid arthritis joint destruction","volume":"30","author":"Xu","year":"2015","journal-title":"J Bone Miner Res"},{"key":"R15-20261109","doi-asserted-by":"crossref","first-page":"109130","DOI":"10.1016\/j.intimp.2022.109130","article-title":"Interleukin-6 cytokine: an overview of the immune regulation, immune dysregulation, and therapeutic approach","volume":"111","author":"Aliyu","year":"2022","journal-title":"Int Immunopharmacol"},{"key":"R16-20261109","first-page":"117\u201326","article-title":"TGF-beta type I receptor kinase inhibitor down-regulates rheumatoid synoviocytes and prevents the arthritis induced by type II collagen antibody","volume":"19","author":"Sakuma","year":"2007","journal-title":"Int Immunol"},{"key":"R17-20261109","doi-asserted-by":"crossref","first-page":"128\u201336","DOI":"10.1053\/joca.2000.0368","article-title":"Overexpression of active TGF-beta-1 in the murine knee joint: evidence for synovial-layer-dependent chondro-osteophyte formation","volume":"9","author":"Bakker","year":"2001","journal-title":"Osteoarthritis Cartilage"},{"key":"R18-20261109","doi-asserted-by":"crossref","first-page":"656\u201364","DOI":"10.1038\/nrrheum.2012.153","article-title":"Bone erosion in rheumatoid arthritis: mechanisms, diagnosis and treatment","volume":"8","author":"Schett","year":"2012","journal-title":"Nat Rev Rheumatol"},{"key":"R19-20261109","doi-asserted-by":"crossref","first-page":"626\u201342","DOI":"10.1038\/s41577-019-0178-8","article-title":"Osteoimmunology: evolving concepts in bone-immune interactions in health and disease","volume":"19","author":"Tsukasaki","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"R20-20261109","article-title":"The balance of Th17 versus treg cells in autoimmunity","volume":"19","author":"Lee","year":"2018","journal-title":"Int J Mol Sci"},{"key":"R21-20261109","doi-asserted-by":"crossref","first-page":"587\u201397","DOI":"10.1002\/hep.22653","article-title":"Recruitment of host progenitor cells in rat liver transplants","volume":"49","author":"Sun","year":"2009","journal-title":"Hepatology"},{"key":"R22-20261109","doi-asserted-by":"crossref","first-page":"2046\u201356","DOI":"10.1111\/j.1600-6143.2011.03698.x","article-title":"Mobilization of host stem cells enables long-term liver transplant acceptance in a strongly rejecting rat strain combination","volume":"11","author":"Okabayashi","year":"2011","journal-title":"Am J Transplant"},{"key":"R23-20261109","doi-asserted-by":"crossref","first-page":"2458\u201368","DOI":"10.1038\/jid.2014.162","article-title":"Pharmacological mobilization of endogenous stem cells significantly promotes skin regeneration after full-thickness excision: the synergistic activity of AMD3100 and tacrolimus","volume":"134","author":"Lin","year":"2014","journal-title":"J Invest Dermatol"},{"key":"R24-20261109","doi-asserted-by":"crossref","first-page":"2055\u201365","DOI":"10.1111\/ajt.13706","article-title":"Chimeric allografts induced by short-term treatment with stem cell-mobilizing agents result in long-term kidney transplant survival without immunosuppression: a study in rats","volume":"16","author":"Hu","year":"2016","journal-title":"Am J Transplant"},{"key":"R25-20261109","doi-asserted-by":"crossref","first-page":"699\u2013712","DOI":"10.2337\/db19-0907","article-title":"Major improvement in wound healing through pharmacologic mobilization of stem cells in severely diabetic rats","volume":"69","author":"Qi","year":"2020","journal-title":"Diabetes"},{"key":"R26-20261109","doi-asserted-by":"crossref","first-page":"3587","DOI":"10.1038\/s41598-018-21961-2","article-title":"Pharmacological mobilization of endogenous bone marrow stem cells promotes liver regeneration after extensive liver resection in rats","volume":"8","author":"Zhai","year":"2018","journal-title":"Sci Rep"},{"key":"R27-20261109","doi-asserted-by":"crossref","first-page":"7149","DOI":"10.1038\/s41598-019-43734-1","article-title":"Pharmacological mobilization and recruitment of stem cells in rats stops abdominal adhesions after laparotomy","volume":"9","author":"Iwasaki","year":"2019","journal-title":"Sci Rep"},{"key":"R28-20261109","doi-asserted-by":"crossref","first-page":"234\u201341","DOI":"10.1093\/jbcr\/irad153","article-title":"Induction of skin allograft chimerism by pharmacological mobilization of endogenous bone marrow-derived stem cells","volume":"45","author":"Ahmadi","year":"2024","journal-title":"J Burn Care Res"},{"key":"R29-20261109","doi-asserted-by":"crossref","first-page":"2066\u201376","DOI":"10.1111\/ajt.13703","article-title":"Chimeric allografts induced by short-term treatment with stem cell mobilizing agents result in long-term kidney transplant survival without immunosuppression: II, study in miniature swine","volume":"16","author":"Cameron","year":"2016","journal-title":"Am J Transplant"},{"key":"R30-20261109","doi-asserted-by":"crossref","first-page":"282\u201388","DOI":"10.1159\/000315736","article-title":"FDA review summary: mozobil in combination with granulocyte colony-stimulating factor to mobilize hematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation","volume":"78","author":"Brave","year":"2010","journal-title":"Oncology"},{"key":"R31-20261109","doi-asserted-by":"crossref","first-page":"120\u201322","DOI":"10.4161\/chim.2.4.19177","article-title":"Host stem cells repopulate liver allografts: reverse chimerism","volume":"2","author":"Sun","year":"2011","journal-title":"Chimerism"},{"key":"R32-20261109","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/nrgastro.2011.178","article-title":"Transplantation: host stem cells boost tolerance of liver grafts","volume":"8","author":"Ray","year":"2011","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R33-20261109","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/nrneph.2016.8","article-title":"Transplantation: reverse chimerism enables graft acceptance","volume":"12","author":"Carney","year":"2016","journal-title":"Nat Rev Nephrol"},{"key":"R34-20261109","doi-asserted-by":"crossref","first-page":"101169","DOI":"10.1016\/j.xcrm.2023.101169","article-title":"A phase I, first-in-human study to evaluate the safety and tolerability, pharmacokinetics, and pharmacodynamics of MRG-001 in healthy subjects","volume":"4","author":"Ahmadi","year":"2023","journal-title":"Cell Rep Med"},{"key":"R35-20261109","doi-asserted-by":"crossref","first-page":"1269\u201375","DOI":"10.1038\/nprot.2007.173","article-title":"Collagen-induced arthritis","volume":"2","author":"Brand","year":"2007","journal-title":"Nat Protoc"},{"key":"R36-20261109","doi-asserted-by":"crossref","first-page":"e85553","DOI":"10.7554\/eLife.85553","article-title":"RANK(+)TLR2(+) myeloid subpopulation converts autoimmune to joint destruction in rheumatoid arthritis","volume":"12","author":"Zhang","year":"2023","journal-title":"Elife"},{"key":"R37-20261109","doi-asserted-by":"crossref","first-page":"2512\u201316","DOI":"10.1038\/nprot.2006.393","article-title":"Collagen antibody-induced arthritis","volume":"1","author":"Khachigian","year":"2006","journal-title":"Nat Protoc"},{"key":"R38-20261109","doi-asserted-by":"crossref","first-page":"e1000412","DOI":"10.1371\/journal.pbio.1000412","article-title":"Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research","volume":"8","author":"Kilkenny","year":"2010","journal-title":"PLoS Biol"},{"key":"R39-20261109","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.79773","article-title":"Senescent preosteoclast secretome promotes metabolic syndrome associated osteoarthritis through cyclooxygenase 2","volume":"11","author":"Su","year":"2022","journal-title":"Elife"},{"key":"R40-20261109","doi-asserted-by":"crossref","DOI":"10.1172\/JCI168155","article-title":"Proton-activated chloride channel increases endplate porosity and pain in a mouse spine degeneration model","volume":"134","author":"Xue","year":"2024","journal-title":"J Clin Invest"},{"key":"R41-20261109","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3389\/fnmol.2017.00284","article-title":"Methods used to evaluate pain behaviors in rodents","volume":"10","author":"Deuis","year":"2017","journal-title":"Front Mol Neurosci"},{"key":"R42-20261109","first-page":"rs.3.rs\u20134823095","article-title":"Slit3 by PTH-induced osteoblast secretion repels sensory innervation in spine porous endplates to relieve low back pain","author":"Crane","year":"2024","journal-title":"Res Sq"},{"key":"R43-20261109","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/j.joca.2010.05.025","article-title":"The OARSI histopathology initiative - recommendations for histological assessments of osteoarthritis in the mouse","volume":"18","author":"Glasson","year":"2010","journal-title":"Osteoarthritis Cartilage"},{"key":"R44-20261109","doi-asserted-by":"crossref","first-page":"233\u201355","DOI":"10.1111\/j.0105-2896.2009.00859.x","article-title":"Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis","volume":"233","author":"Bartok","year":"2010","journal-title":"Immunol Rev"},{"key":"R45-20261109","doi-asserted-by":"crossref","first-page":"403\u201340","DOI":"10.1210\/er.2007-0038","article-title":"Osteoimmunology: interactions of the bone and immune system","volume":"29","author":"Lorenzo","year":"2008","journal-title":"Endocr Rev"},{"key":"R46-20261109","doi-asserted-by":"crossref","first-page":"667\u201376","DOI":"10.1038\/nrrheum.2009.217","article-title":"Osteoimmunology and the effects of the immune system on bone","volume":"5","author":"Takayanagi","year":"2009","journal-title":"Nat Rev Rheumatol"},{"key":"R47-20261109","doi-asserted-by":"crossref","first-page":"1015\u201323","DOI":"10.1002\/art.33446","article-title":"Interleukin-22 promotes osteoclastogenesis in rheumatoid arthritis through induction of RANKL in human synovial fibroblasts","volume":"64","author":"Kim","year":"2012","journal-title":"Arthritis Rheum"},{"key":"R48-20261109","doi-asserted-by":"crossref","first-page":"e169754","DOI":"10.1172\/JCI169754","article-title":"Autoimmunity to stromal-derived autoantigens in rheumatoid ectopic germinal centers exacerbates arthritis and affects clinical response","volume":"134","author":"Corsiero","year":"2024","journal-title":"J Clin Invest"},{"key":"R49-20261109","doi-asserted-by":"crossref","first-page":"958","DOI":"10.3389\/fimmu.2020.00958","article-title":"C-reactive protein promotes the activation of fibroblast-like synoviocytes from patients with rheumatoid arthritis","volume":"11","author":"Fang","year":"2020","journal-title":"Front Immunol"},{"key":"R50-20261109","doi-asserted-by":"crossref","first-page":"174500","DOI":"10.1016\/j.ejphar.2021.174500","article-title":"Angiogenesis as a potential treatment strategy for rheumatoid arthritis","volume":"910","author":"Wang","year":"2021","journal-title":"Eur J Pharmacol"},{"key":"R51-20261109","first-page":"603\u201339","article-title":"Angiogenesis in rheumatoid Arthritis: pathological characterization, pathogenic mechanisms, and nano-targeted therapeutic strategies","volume":"50","author":"Zhao","year":"2025","journal-title":"Bioact Mater"},{"key":"R52-20261109","doi-asserted-by":"crossref","first-page":"153\u201362","DOI":"10.1038\/nrrheum.2011.205","article-title":"Hypoxia\u2013a key regulator of angiogenesis and inflammation in rheumatoid arthritis","volume":"8","author":"Konisti","year":"2012","journal-title":"Nat Rev Rheumatol"},{"key":"R53-20261109","doi-asserted-by":"crossref","first-page":"323\u201328","DOI":"10.1038\/nature13145","article-title":"Coupling of angiogenesis and osteogenesis by a specific vessel subtype in bone","volume":"507","author":"Kusumbe","year":"2014","journal-title":"Nature"},{"key":"R54-20261109","doi-asserted-by":"crossref","first-page":"1668\u201377","DOI":"10.1002\/art.39082","article-title":"Calcitonin gene-related peptide-expressing sensory neurons and spinal microglial reactivity contribute to pain states in collagen-induced arthritis","volume":"67","author":"Nieto","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"R55-20261109","doi-asserted-by":"crossref","first-page":"eadk3506","DOI":"10.1126\/scitranslmed.adk3506","article-title":"Synovial fibroblast gene expression is associated with sensory nerve growth and pain in rheumatoid arthritis","volume":"16","author":"Bai","year":"2024","journal-title":"Sci Transl Med"},{"key":"R56-20261109","doi-asserted-by":"crossref","first-page":"155\u201367","DOI":"10.1016\/S0049-0172(03)00134-3","article-title":"Cyclooxygenase-2 and prostaglandins in articular tissues","volume":"33","author":"Martel-Pelletier","year":"2003","journal-title":"Semin Arthritis Rheum"},{"key":"R57-20261109","doi-asserted-by":"crossref","first-page":"61\u201369","DOI":"10.1080\/14397595.2020.1719607","article-title":"Efficacy and safety of tacrolimus in patients with rheumatoid arthritis - A systematic review and meta-analysis","volume":"31","author":"Kaneko","year":"2021","journal-title":"Mod Rheumatol"},{"key":"R58-20261109","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.chembiol.2019.01.011","article-title":"Activation of BMP signaling by FKBP12 ligands synergizes with inhibition of CXCR4 to accelerate wound healing","volume":"26","author":"Peiffer","year":"2019","journal-title":"Cell Chem Biol"},{"key":"R59-20261109","doi-asserted-by":"crossref","first-page":"503\u201310","DOI":"10.1016\/j.intimp.2004.10.012","article-title":"FK506 ameliorates spontaneous locomotor activity in collagen-induced arthritis: implication of distinct effect from suppression of inflammation","volume":"5","author":"Sasakawa","year":"2005","journal-title":"Int Immunopharmacol"},{"key":"R60-20261109","doi-asserted-by":"crossref","first-page":"524\u201329","DOI":"10.1007\/s00011-003-1210-8","article-title":"Anti-arthritic properties of FK506 on collagen-induced arthritis in rats","volume":"52","author":"Magari","year":"2003","journal-title":"Inflamm Res"}],"container-title":["International Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/JS9.0000000000005353","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T09:01:09Z","timestamp":1794214869000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/JS9.0000000000005353"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,30]]},"references-count":60,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/js9.0000000000005353","relation":{},"ISSN":["1743-9159","1743-9191"],"issn-type":[{"value":"1743-9159","type":"electronic"},{"value":"1743-9191","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4,30]]},"assertion":[{"value":"2025-09-29","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-28","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}